ArticleBone marrow transplantation2026

Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study.

Chenxue Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.